Blog

Against the challenging backdrop of a global pandemic, 2020 saw the successful merger of UKI2S portfolio company Perfectus Biomed and US-based Extherid Biosciences. There are of course specific challenges for a UK/US merger, but the value of cross-cultural collaboration across all levels of the business should be celebrated particularly for the personal growth and development […]

read more

2021 is set to be an interesting year for gene editing. Gene therapy research is in its adolescence, and the ups and downs are played out almost every day, with plenty of innovative breakthroughs and a few regulatory setbacks. With lots of unknowns and much to be excited about, we spoke with Jon Moore, Executive […]

read more

The UK is at the forefront of fusion energy research and development, hosting the EU’s Joint European Torus (JET), the world’s leading fusion machine, as well as a growing ecosystem of public and privately funded initiatives. The UK government recently announced funding of £220m for the UK Atomic Energy Authority, which hosts JET at its […]

read more

1 2 3 36